Chylomicron retention disease in a 2-year-old girl with a novel deletion in the SAR1b gene: A case report and literature review by Ibrahim, Judy et al.
Vol 5 | Issue 11 | November 2018 Indian J Child Health 699
Case Report
Chylomicron retention disease in a 2-year-old girl with a novel deletion in the 
SAR1b gene: A case report and literature review
Judy Ibrahim1, Nuha Al Zaabi2, Jozef Hertecant3
From 1Resident, Departments of Pediatrics, 2Fellow, Department of Pediatrics Genetics and Metabolics Diseases, 3Consultant, Department of 
Pediatrics Genetics and Metabolics, Tawam Hospital-affiliated to John Hopkins, Al Ain, United Arab Emirates
Correspondence to: Judy Ibrahim, 46th Street Bida Bin Amar, Ashrej, Al Ain, Abu Dhabi, UAE. E-mail: drjudyibrahim@gmail.com
Received - 22 August 2018 Initial Review - 21 September Accepted - 03 November 2018
Chylomicron retention disease (CMRD or CRD), also called Anderson’s disease (AD), is a rare autosomal recessive disorder of lipid absorption (OMIM 246700). Anderson 
et al. first described it in 1961 [1]. More than four decades later, 
in 2003, SAR1B gene was identified as the responsible gene [2]. 
Our patient had a new variant of mutation in the SAR1B gene that 
was not described before as per the American College of Medical 
Genetics and Genomics (ACMG).
The diagnosis of CMRD often gets delayed due to the rarity 
of the disease and the non-specific presentation, as happened in 
our case. We are reporting this case also to explain the avoidable 
delay in initiation of treatment, which happened due to waiting 
for genetic confirmation.
CASE REPORT
A 2-year-old girl was referred to our clinic for failure to thrive 
and chronic diarrhea. She was born in Egypt at full term by a 
C-section due to a previous C-section, and her birth weight was 
2.5 kg. At the age of 1 month, she faced the bleeding problem as a 
result of ear piercing due to this complication; she was admitted to 
the hospital and treated with a transfusion of fresh frozen plasma 
as well as Vitamin K supplementation. Her bleeding workup 
afterward included coagulation profile, factor assays, and platelet 
function tests which were within normal limits.
Around the age of 4 months, she suffered from diarrhea and 
was passing stool up to 5 times/day; the stool was described as 
oily, bulky, and foul smelling. She was only on breastfeeding at 
that time; her mother had tried formula supplementation, after 
which the baby had persistent vomiting. This resolved by the age 
of 6 months. By the age of 9 months, there was obvious failure to 
thrive and the family started seeking medical advice. Initially, she 
was investigated and started on a high-calorie formula through 
nasogastric tube, but her weight and height remained below the 
third percentile. The child also had features of rickets; frontal 
bossing, protrusion of the abdomen, and bowing of legs. The 
child was started on Vitamin D supplement. The family also gave 
a history of recurrent infections; one of which required pediatric 
intensive care unit for 1 week along with this. She also had 
persistent oral thrush.
The patient’s parents were 4th-degree cousins; she had one 
sibling, an elder brother, who was healthy. Her development was 
delayed for all her milestones; she was able to sit independently 
at the age of 18 months and started walking independently at the 
age of 22 months. She could hold a pen and scribble but could not 
take off her shoes. She was only using single words, had a very 
limited vocabulary of around 10 words and knew only one body 
part.
On examination; her weight was 8.2 kg (below 3rd centile on 
CDC growth charts, z-score - 3.82), length was 73 cm (below 3rd 
centile, z-score - 3.27), and head circumference was 44 cm (on 
2nd centile, z-score - 1.99). She had been on those centiles since 
the age of 7 months, but she was vitally stable and generally well, 
with no distinctive features. She had frontal bossing as mentioned 
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earlier and her limbs were wasted and bowed, and her abdomen 
was distended. Her gait was clumsy, no truncal ataxia. Rest of the 
physical examination was unremarkable.
An initial work-up revealed normocytic normochromic 
anemia (hemoglobin = 105 g/L, hematocrit = 0.32 L/L, mean 
corpuscular volume = 75.5 fL, and mean corpuscular hemoglobin 
= 24.5 pg) with no acanthocytes on blood smear. Her prothrombin 
time was 21.1 with international normalized ratio of 1.8 (0.86–
1.22), which normalized with oral Vitamin K. The other fat-
soluble vitamins were also low: Vitamin A 135 µg/L (194–421), 
Vitamin E <1.40 mg/L (3.02–9.05), and Vitamin D 35.9 nmol/L 
(52–250). Total cholesterol was 1.99 mmol/L (1.15–4.70), high-
density lipoprotein 0.42 mmol/L (0.91–2.12), and low-density 
lipoprotein (LDL) 1.05 mmol/L (1.63–3.63), but triglyceride 
levels were 1.14 mmol/L (0.31–1.41); these levels did not change 
significantly after a fat challenge. ApoA1 level was 0.7 g/L (1.08–
2.25), ApoB level was 0.84 g/L (0.6–1.17), and ApoB/ApoA1 
was 1.2.
She had a normal absolute neutrophil count and lymphocytes 
count, as well as normal lymphocytes subset counts, CH50, and 
immunoglobulin levels on multiple repeated tests. She also had 
normal celiac profile and a negative sweat chloride test while her 
detailed ophthalmic examination was normal.
She underwent colonoscopy and histopathology in her country 
of origin; which reported snowflake appearance of the duodenum. 
The biopsy reported mild villous atrophy and vacuolated 
intestinal cells. Thus, at the age of 24 months, child’s clinical and 
para-clinical picture was strongly hinting toward CRD (as was 
already suspected in her country of origin, but treatment was not 
started, rather, the child was referred to the hospital for genetic 
investigations). Due to financial reasons, the process of arranging 
for the confirmatory genetic study was lengthy. Expecting this 
delay, we put the child immediately on dietary restrictions which 
are recommended for CRMD. We started high protein low-fat 
diet (special formula rich in medium chain fatty acid and low in 
long chain fatty acid). A follow-up in 1 week showed significant 
weight gain (i.e., 1.3 kg, 16.3% of her presentation weight). Her 
diarrhea improved to twice daily and her gait became more stable. 
The child’s feeding regimen was adjusted, and she was followed 
up closely for her risk of developing refeeding syndrome.
Meanwhile, her genetic studies yielded a normal sequence 
analysis of the SAR1B gene without pathogenic variants, but 
could not amplify exon 3. A deletion/duplication analysis of the 
SAR1B gene revealed a homozygous deletion encompassing 
exon 3 (NM_001033503.2; quantitative polymerase chain 
reaction). It is classified as pathogenic (Class 1) according to the 
recommendations of the ACMG. According to our lab, it was the 
1st time this variant had been detected. Genetic counseling was 
done, but neither of the parents could undergo genetic testing due 
to financial limitations.
Gradually over the next year, the child’s weight caught up to 
35th centile, her diarrhea subsided, and her abdominal distension 
improved. She had a steady gait and a normal neurological 
examination follow up. The child had started to achieve her 
developmental milestones. She was also kept on A, D, E, and 
K Vitamins supplementation with close monitoring to ensure 
normal levels.
DISCUSSION
Around 62 cases had been described in literature, of these, 43 
have proven alterations in the SAR1B gene on chromosome 5; 
these include 20 different mutations and deletions [3]. Information 
concerning the SAR1B genes in the other patients has not been 
published [4]. Our patient has a homozygous deletion of exon 3, 
which has not been described before.
SAR1B gene translates into a protein product belongs to the 
Sar1-ADP-ribosylation factor family of small GTPases. This 
family plays a critical role in the transport of proteins from 
the endoplasmic reticulum to the Golgi apparatus [5]. It is also 
involved in the hepatic secretion of very LDL. The SAR1B protein 
has another isoform, the SAR1A; however, overexpression 
of SAR1A found in CMRD patients could not compensate the 
SAR1B suppression [6,7].
There is only one case in which CMRD was not associated 
with any mutation in SAR1B gene, in a 5-year-old Japanese boy 
with uniparental disomy of chromosome 7, and a normal SAR1B 
gene code sequencing [8]. This suggests that other factors might 
be contributing to lipid absorption.
AD manifests in infancy or early childhood with steatorrhea, 
failure to thrive and symptoms of fat-soluble vitamins deficiency. 
Myopathy has been reported in some patients. Hepatomegaly and 
hepatic steatosis are also reported in a few published cases [4]. 
Patients have low total plasma cholesterol level and low LDL but 
normal triglycerides. There is a selective absence of apoB48 in 
the postprandial state. Usually, no acanthocytes are seen on blood 
film unless there is an advanced liver disease. Endoscopy shows 
normal esophageal and gastric mucosa, whereas the duodenal 
mucosa looks white with a specific pattern often described as 
snowflake appearance. Biopsy, generally, shows normal villi, 
but sometimes mild atrophy is found, as in our patient. Typically, 
enterocytes are multi-vacuolated, the so-called “fat-filled 
enterocytes.”
The diagnosis of CMRD often gets delayed and the low 
lipid profile is often attributed to the malabsorption itself. When 
diagnosed in adulthood, the manifestations are usually more 
severe. Apart from the malabsorption and the failure to thrive, this 
disease also causes complications due to the poor absorption of the 
fat-soluble vitamins. Long-standing Vitamin E deficiency causes 
degenerative nerve disease such as proprioceptive abnormalities, 
polyneuropathy, and ataxia. Vitamin A deficiency causes delayed 
dark adaptation. The complications of Vitamin D deficiency are 
well known and have been described in patients with delayed 
diagnosis of CMRD.
In our patient, the diagnosis was suspected early on, but the 
treatment was delayed. A trial of fat restricted diet resulted in a 
fast and spectacular improvement. This supported the working 
diagnosis which could not be confirmed until later on. We suggest 
that a therapeutic trial should be the preferred approach if genetic 
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confirmation is not feasible, as often happens in resource-poor 
countries.
Management of CMRD focuses on (1) exclusion of long-
chain fatty acids from diet, to decrease the fat load inside in the 
enterocytes and promote absorption, and (2) supplementation with 
fat-soluble vitamins to prevent vitamin deficiency syndromes, 
most importantly Vitamin E [3].
A close follow-up of CMRD patients is crucial. The aim is 
to maintain a sufficient level of Vitamin E and hence prevention 
of neurologic complications. It is challenging since plasma 
concentration level usually does not reflect the vitamin status of 
tissues. It has been suggested to measure the concentrations of 
Vitamin E in erythrocyte membranes for treatment adjustments, 
and adipose tissue; as a measurement of vitamin reserve and 
long-term compliance. Reference values are available in 
children [9]. Although CMRD is a rare entity, Peretti et al. 
suggested an approach for its diagnosis and management in 
2010 based on literature review and experience of two centers 
(Figs. 1 and 2) [10]
CONCLUSION
CMRD is a rare disease of hypocholesterolemia; more research 
is required to understand its pathophysiology and contributing 
factors. When the diagnosis is suspected a therapeutic trial with 
diet seems indicated, especially in resource-restricted countries. 
This supports the diagnosis and helps to prevent its devastating 
complications.
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